A striking phenomenon is emerging from China as the Middle East conflict presses on: technically skilled civilians are volunteering their expertise online to help Iran counter US military might, ...

Earnings call Sangamo reported significant progress in its Fabry disease program, including positive clinical data and ongoing FDA BLA submission, while raising over $130 million in 2025. However, the ...

Good afternoon, and welcome to the Sangamo Therapeutics Fourth Quarter and Full Year 2025 Teleconference Call. Please be advised that today's conference is being recorded. I would now like to turn the ...

Sangamo missed EPS and revenue forecasts significantly, indicating financial challenges. The stock saw a 9.04% rise in aftermarket trading despite the earnings miss. Strategic partnerships and capital ...

New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial documentation and execution. ATLANTA, GA, UNITED ...

Inclusion criteria include the patient being high risk for open surgical repair. The clinical module of the PMA is anticipated to be filed after completion of one year of follow up with the 54 ...